论文部分内容阅读
为探讨乳癌术前细针针吸细胞学选择性替代术中切除活检的可能性，对１９９５年９月～１９９６年５月间住院手术治疗的１１８例“乳房肿块”病人均行了术前临床触诊及细针针吸细胞学检查。结果显示：１１８例病人病理证实为乳癌者６９例。细针针吸细胞学检查诊断乳癌灵敏度为９５．７％，阳性预测值为９７．１％。当触诊与细针针吸均阳性时，其联合诊断乳癌的灵敏度仅为４７．８％，但联合阳性预测值却达到１００％。提示：对于住院接受手术的乳腺肿块病人，如果术前触诊能基本肯定为乳癌，则应行细针针吸细胞学检查；若针吸涂片查到癌细胞，则可免除术中切除活检而直接行根治性手术
To investigate the possibility of selective bioartificial replacement of fine needle aspiration cytology for breast cancer, 118 patients with breast lumps who underwent surgery between September 1995 and May 1996 were treated preoperatively. Palpation and fine needle aspiration cytology. The results showed that: 118 cases of pathologically confirmed breast cancer were 69 cases. Fine-needle aspiration cytology was used to diagnose breast cancer with a sensitivity of 95.7% and a positive predictive value of 97.1%. When both palpation and fine needle aspiration were positive, the combined diagnostic sensitivity of breast cancer was only 47.8%, but the combined positive predictive value was 100%. Tip: For hospitalized breast tumor patients, if the preoperative palpation can be confirmed as breast cancer, fine-needle aspiration cytology examination should be performed; if the needle aspiration smear found cancer cells, excisional biopsy can be exempted. Direct radical surgery